The results of in vivo tumor growth assays exhibited that LYPLAL1-DT-generated smaller tumors and suppressed weights of tumors regained malignant nature by virtue of β-catenin-dependent facilitated tumor growth (Fig. 7H and I). This evidence concerns the gene LYPLAL1 and neoplasm.